RebrandingAug 3, 2026, 08:03 AM
The Oncology Institute Rebrands to Starling Oncology; New Ticker STLN
AI Summary
The Oncology Institute, Inc. has rebranded to Starling Oncology, Inc., effective August 3, 2026. Its common stock will begin trading under the new Nasdaq ticker symbol "STLN" on August 4, 2026, replacing "TOI." CEO Dan Virnich stated the rebrand reflects the company's growth, profitability, and evolution into an integrated oncology platform, emphasizing its commitment to high-quality, value-based cancer care without disruption to patients.
Key Highlights
- The Oncology Institute, Inc. rebranded to Starling Oncology, Inc.
- New Nasdaq ticker symbol "STLN" will be effective August 4, 2026.
- The new ticker "STLN" replaces the previous ticker symbol "TOI."
- CEO Dan Virnich stated the rebrand reflects the company's scale and upward trajectory.
- The rebrand marks an evolution into an integrated oncology platform.
- The company's mission remains focused on high-quality, patient-centered cancer care.
Price Impact
More from TOI